Travelzoo Inc. (TZOO) Drops 6.2% on February 02

Equities Staff |

Travelzoo Inc. (TZOO) was one of the Russell 2000's biggest losers for Tuesday February 02 as the stock slid 6.2% to $7.41, a loss of $-0.49 per share. Starting at an opening price of $7.78 a share, the stock traded between $7.41 and $7.87 over the course of the trading day. Volume was 17,251 shares over 170 trades, against an average daily volume of 67,041 shares and a total float of 14.73 million.

The losses send Travelzoo Inc. down to a market cap of $109.15 million. In the last year, Travelzoo Inc. has traded between $14.29 and $6.77, and its 50-day SMA is currently $8.11 and 200-day SMA is $9.86.

The stock has a P/E Ratio of 8.7.

Travelzoo Inc. is an Internet media company, which informs over 27 million subscribers, as well as millions of Web site users, about the travel and entertainment deals available from thousands of Companies.

Travelzoo Inc. is based out of New York, NY and has some 395 employees. Its CEO is Holger Bartel / Christopher Loughlin.

For a complete fundamental analysis analysis of Travelzoo Inc., check out Equities.com’s Stock Valuation Analysis report for TZOO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…